Clinical Trial Update: SPironolactONe for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial update for spironolactone in maintaining sinus rhythm in patients with recurrent atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University Hospital, Caen | Conditions: Atrial Fibrillation Recurrent | Phase 3 | Status: NOT_YET_RECRUITING